Penn Medicine Provider
Ebbing Lautenbach, MD, MPH, MSCE
Make an appointmentCall 800-789-7366

About me

  • Chief, Division of Infectious Diseases
  • Associate Director, Clinical Epidemiology Unit and Senior Scholar, Center for Clinical Epidemiology & Biostatistics
  • Robert Austrian Professor
  • Professor of Epidemiology in Biostatistics and Epidemiology

Ebbing Lautenbach, MD, MPH, MSCE earned a BS in Chemistry and Psychology at Calvin College followed by an MD and MPH at Columbia University, College of Physicians and Surgeons. He came to the University of Pennsylvania for residency in Internal Medicine, followed by a fellowship in Infectious Diseases during which time he also earned a Master of Science in Clinical Epidemiology (MSCE). Dr. Lautenbach is the Robert Austrian Professor of Medicine (Infectious Diseases) and Professor of Epidemiology at Penn. He also serves as the Chief of the Division of Infectious Diseases and is a Senior Scholar in the Center for Clinical Epidemiology and Biostatistics (CCEB), a Fellow in the Institute on Aging, Senior Fellow at the Leonard Davis Institute on Health Economics, and a Senior Fellow at the Center for Public Health Initiatives. He serves as the Associate Director of the CCEB for Educational Programs. Dr. Lautenbach’s research focuses on the epidemiology, treatment, and prevention of healthcare-associated infections, particularly those due to antimicrobial resistant pathogens. He has lectured extensively and has over 250 peer-reviewed publications in these areas. He has received numerous foundation, state and federal grants to support his research focusing on antimicrobial resistance. Dr. Lautenbach is a Fellow in the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), the American College of Physicians (ACP) and the College of Physicians of Philadelphia. He is an elected member of American Society for Clinical Investigation (ASCI) and the Association of American Physicians (AAP).

Education and training

  • Medical School: Columbia University
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: Hospital of the University of Pennsylvania

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Lautenbach is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Hostler CJ, Krishnan J, Parish A, Baroco A, Cooper P, Donceras O, Lautenbach E, Tolomeo P, Sansossio T, Santos CAQ, Schwartz D, Zhang H, Welbel S, Lokhnygina Y, Anderson D CDC Prevention Epicenters Program. Postoperative outcomes after receipt of ertapenem antimicrobial prophylaxis for colon surgery: a multicenter retrospective cohort study. Infect Control Hosp Epidemiol , doi: 10.1017/ice.2024.99, 4(45): 2024,1-6

Moore K, Lautenbach E, Blumberg EA, Han J, Lee DH, Clauss H, Hasz R, Bilker WB, Molnar E, Alimenti D, West S, Tolomeo P, Anesi JA Impact of deceased organ donor marijuana use on donor culture positivity and solid organ transplant recipient outcomes , doi: 10.1016/j.ajt.2024.02.022, 8(1): 2024,1427-1439

Choi J, Thänert R, Reske KA, Nickel KB, Olsen MA, Hink T, Thänert A, Wallace MA, Wang B, Cass C, Barlet MH, Struttmann EL, Iqbal ZH, Sax SR, Fraser VJ, Baker AW, Foy KR, Williams B, Xu B, Capocci-Tolomeo P, Lautenbach E, Burnham CD, Dubberke ER, Dantas G, Kwon JH CDC Prevention Epicenters Program. Gut microbiome correlates of recurrent urinary tract infection: a longitudinal, multi-center study EClinicalMedicine , doi: 10.1016/j.eclinm.2024.102490, 26(71): 2024,1024

Zhang HL, Perez R, Krishnan J, Lautenbach E, Anderson DJ. Risk Factors for Recurrence of Community-Onset Urinary Tract Infections Caused by Extended-Spectrum Cephalosporin-Resistant Enterobacterales , Open Forum Infect Dis., 10(12): 2023

Mannathoko N, Lautenbach E, Mosepele M, Otukile D, Sewawa K, Glaser L, Cressman L, Cowden L, Alby K, Jaskowiak-Barr A, Gross R, Mokomane M, Paganotti GM, Styczynski A, Smith RM, Snitkin E, Wan T, Bilker WB, Richard-Greenblatt M.J Performance of CHROMagar ESBL media for the surveillance of extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) from rectal swabs in Botswana , Med Microbiol. , 72(11): 2023

Lautenbach E, Mosepele M, Smith RM, Styczynski A, Gross R, Cressman L, Jaskowiak-Barr A, Alby K, Glaser L, Richard-Greenblatt M, Cowden L, Sewawa K, Otukile D, Paganotti GM, Mokomane M, Bilker WB, Mannathoko N. Risk Factors for Community Colonization With Extended-Spectrum Cephalosporin-Resistant Enterobacterales (ESCrE) in Botswana: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study , Clin Infect Dis. , 77(Suppl 1): 2023,S89-S96

Zhang HL, Gontjes KJ, Han JH, Alby K, Lapp Z, Snitkin E, Goldstein EJC, Muldoon S, Tolomeo P, Lautenbach E.Infect Characterization of resistance to newer antimicrobials among carbapenem-resistant Klebsiella pneumoniae in the post-acute-care setting. , Control Hosp Epidemiol., 44(7): 2023,1159-1162

Tsalik EL, Rouphael NG, Sadikot RT, Rodriguez-Barradas MC, McClain MT, Wilkins DM, Woods CW, Swamy GK, Walter EB, El Sahly HM, Keitel WA, Mulligan MJ, Tuyishimire B, Serti E, Hamasaki T, Evans SR, Ghazaryan V, Lee MS, Lautenbach E; TRAP-LRTI Study Group; Antibacterial Resistance Leadership Group Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial , Lancet Infect Dis., 23(4): 2023,484-495

Cotter CJ, Ferradas C, Ludwig S, Dalton K, Larsen J, Laucks D, Iverson SA, Baron P, Tolomeo PC, Brazil AM, Ferguson JM, Lautenbach E, Rankin SC, Morris DO, Davis Risk factors for meticillin-resistant Staphylococcus aureus (MRSA) carriage in MRSA-exposed household pets. , MF.Vet Dermatol., 34(1): 2023,22-27

Anesi JA, Lautenbach E, Thom KA, Tamma PD, Blumberg EA, Alby K, Bilker WB, Werzen A, Ammazzalorso A, Tolomeo P, Omorogbe J, Pineles L, Han JH Clinical Outcomes and Risk Factors for Carbapenem-resistant Enterobacterales Bloodstream Infection in Solid Organ Transplant Recipients , Transplantation, 107(1): 2023,254-263

View all publications